Is Axsome Therapeutics, Inc. (AXSM) a Buy, Sell, or Hold?
Axsome Therapeutics, Inc.
NASDAQ:AXSM
$235.26 USD
$6.98 (3.06%)
- Volume
- 482.76K
- Average Volume
- 923.51K
- Market Capitalization
- $12.11B
- P/E Ratio
- -63.07
- Dividend Yield
- 0.00%
- Price Target
- $259.50
- Year High
- $260.19
- Year Low
- $96.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.39
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
1.23%
Investors Holding
24
change: -406 | last: 430
Increased Positions
10
change: -205 | last: 215
Reduced Positions
5
change: -140 | last: 145
New Positions
7
change: -64 | last: 71
Sold Positions
396
change: 334 | last: 62
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -93.9007 | last: 0.939
Total Invested
146.83M
AXSM Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $182.64 | 49.75M | $9.09B | $322.93M | $241.3M | $9B |
| 2024-12-31 | $84.61 | 47.91M | $4.05B | $315.35M | $192.96M | $3.93B |
| 2023-12-31 | $79.59 | 45.43M | $3.62B | $386.19M | $186.37M | $3.42B |
| 2022-12-31 | $77.13 | 40.66M | $3.14B | $200.84M | $94.68M | $3.03B |
| 2021-12-31 | $37.78 | 37.62M | $1.42B | $86.47M | $49.71M | $1.38B |
| 2020-12-31 | $81.47 | 37.21M | $3.03B | $183.88M | $50.12M | $2.9B |
| 2019-12-31 | $103.36 | 34.02M | $3.52B | $219.97M | $19.93M | $3.32B |
| 2018-12-31 | $2.82 | 26.88M | $75.81M | $13.97M | $6.91M | $68.75M |
| 2017-12-31 | $5.60 | 22.76M | $127.48M | $34.02M | $9.93M | $103.39M |
| 2016-12-31 | $6.75 | 19.15M | $129.27M | $36.62M | $9.74M | $102.39M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $169.02 | 51.2M | $8.65B | $305.11M | $219.9M | $8.57B |
| 2025-12-31 | $182.64 | 50.63M | $9.25B | $322.93M | $241.3M | $9.17B |
| 2025-09-30 | $121.45 | 50.02M | $6.08B | $325.27M | $218.6M | $5.97B |
| 2025-06-30 | $104.39 | 49.44M | $5.16B | $303.02M | $217.31M | $5.08B |
| 2025-03-31 | $116.63 | 48.87M | $5.7B | $300.91M | $211.23M | $5.61B |
| 2024-12-31 | $84.61 | 48.54M | $4.11B | $315.35M | $192.96M | $3.98B |
| 2024-09-30 | $89.87 | 48.14M | $4.33B | $327.34M | $192.3M | $4.19B |
| 2024-06-30 | $81.03 | 47.57M | $3.85B | $315.66M | $191.8M | $3.73B |
| 2024-03-31 | $76.99 | 47.39M | $3.65B | $331.44M | $189.43M | $3.51B |
| 2023-12-31 | $79.59 | 47.33M | $3.77B | $386.19M | $186.37M | $3.57B |
| 2023-09-30 | $69.89 | 47.12M | $3.29B | $416.56M | $185.58M | $3.06B |
| 2023-06-30 | $71.86 | 43.67M | $3.14B | $437.11M | $184.71M | $2.89B |